title: Propranolol safety profile in children.
abstract: Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the management of hemangiomas in addition to other indications. The purpose of this review is to evaluate safety and efficacy of propranolol use in the pediatric population, highlighting the most important reported side effects, warnings and precautions.
authors: Cairo University, Egypt.
authors: Mortada
authors: M
authors: El-Shabrawi
authors: Fetouh
authors: F
authors: Hassanin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use*; D000367:Age Factors; D000787:Angina Pectoris / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology; D002493:Central Nervous System Diseases / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology; D002648:Child; D004347:Drug Interactions / Q000502:physiology; D006391:Hemangioma / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006975:Hypertension, Portal / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology; D010673:Pheochromocytoma / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology; D011433:Propranolol / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D011433:Propranolol